SkinJect
develops and commercializes novel drug delivery system for the treatment of non-melanoma skin cancers... Read moreSkinJect
develops and commercializes novel drug delivery system for the treatment of non-melanoma skin cancers... Read more
News
Jul 16, 2024
The American Bazaar
SkinJect: 215 Capital invests $8 million in Medicus Pharma Ltd.
Aug 02, 2021
The Business Journals: Pittsburgh Business Times
SkinJect: Developer of skin cancer treatment raises $1.5M
May 31, 2019
Drug Delivery Business
SkinJect: SkinJect raises $3m for skin cancer treatment patch